Status:
COMPLETED
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3
Lead Sponsor:
Central Teaching Hospital of Peadiatrics, Baghdad
Conditions:
Leukemia, Acute
Eligibility:
All Genders
2-15 years
Brief Summary
Background: acute lymphoblastic leukemia is the most common childhood cancer and relapse is the main reason for treatment failure in childhood acute lymphoblastic leukemia. The aim of this study: is ...
Detailed Description
Six hundred patients diagnosed with acute lymphoblastic leukemia, seventy-nine patients were excluded from study, nine patients died very early before starting induction, seventy patients referred or ...
Eligibility Criteria
Inclusion
- patients diagnosed with acute lymphoplastic leukemia
Exclusion
- patients died before starting induction chemotherapy.
- patients referred to another oncological center.
- those who starting the treatment in another oncological center
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
521 Patients enrolled
Trial Details
Trial ID
NCT05969600
Start Date
January 1 2013
End Date
March 1 2022
Last Update
August 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.